| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 5 |
| 1 | POMALIDOMIDE | 5 |
| 2 | MELPHALAN HYDROCHLORIDE | 4 |
| 3 | CILTACABTAGENE AUTOLEUCEL | 2 |
| 4 | CYCLOPHOSPHAMIDE | 2 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 7 | DEXAMETHASONE | 2 |
| 8 | DEXAMETHASONE 1.5 MG | 2 |
| 9 | IDECABTAGENE VICLEUCEL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDECABTAGENE VICLEUCEL | 2 | 0.0016 |
| 1 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 2 | CILTACABTAGENE AUTOLEUCEL | 2 | 0.0003 |
| 3 | MELPHALAN HYDROCHLORIDE | 4 | 0.0002 |
| 4 | MESNA INJECTION | 1 | 0.0001 |
| 5 | MESNA | 1 | 0.0001 |
| 6 | BLINATUMOMAB | 1 | 0.0001 |
| 7 | PEGFILGRASTIM | 1 | 0.0001 |
| 8 | ROMIPLOSTIM | 1 | 0.0001 |
| 9 | BENDAMUSTINE HCL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Thalidomide Analog [EPC] | 5 | 0.0000 |
| 5 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |